Bayer CropScience Limited

BSE:506285 Voorraadrapport

Marktkapitalisatie: ₹299.1b

Bayer CropScience Balans Gezondheid

Financiële gezondheid criteriumcontroles 5/6

Bayer CropScience has a total shareholder equity of ₹28.5B and total debt of ₹471.0M, which brings its debt-to-equity ratio to 1.7%. Its total assets and total liabilities are ₹46.0B and ₹17.5B respectively. Bayer CropScience's EBIT is ₹8.0B making its interest coverage ratio -24.6. It has cash and short-term investments of ₹12.1B.

Belangrijke informatie

1.7%

Verhouding schuld/eigen vermogen

₹471.00m

Schuld

Rente dekkingsratio-24.6x
Contant₹12.11b
Aandelen₹28.49b
Totaal verplichtingen₹17.48b
Totaal activa₹45.97b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Analyse van de financiële positie

Kortlopende schulden: 506285's short term assets (₹39.1B) exceed its short term liabilities (₹16.0B).

Langlopende schulden: 506285's short term assets (₹39.1B) exceed its long term liabilities (₹1.5B).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 506285 has more cash than its total debt.

Schuld verminderen: 506285's debt to equity ratio has increased from 0% to 1.7% over the past 5 years.

Schuldendekking: 506285's debt is well covered by operating cash flow (2020.4%).

Rentedekking: 506285 earns more interest than it pays, so coverage of interest payments is not a concern.


Balans


Ontdek gezonde bedrijven